Filing Details

Accession Number:
0001179110-22-001832
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-01 18:08:44
Reporting Period:
2022-02-25
Accepted Time:
2022-03-01 18:08:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1551152 Abbvie Inc. ABBV Pharmaceutical Preparations (2834) 320375147
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1761675 Ryan Jeffrey Stewart 1 North Waukegan Road
North Chicago IL 60064
Evp, Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Disposition 2022-02-25 17,093 $149.54 82,429 No 4 F Direct
Common Stock, $0.01 Par Value Disposition 2022-03-01 6,229 $147.43 76,200 No 4 S Direct
Common Stock, $0.01 Par Value Disposition 2022-03-01 12,659 $148.49 63,541 No 4 S Direct
Common Stock, $0.01 Par Value Disposition 2022-03-01 2,600 $149.04 60,941 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.01 Par Value 1,338 Indirect By spouse in trust
Footnotes
  1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.86 to $147.85 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.86 to $148.85 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.86 to $149.48 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The reporting person disclaims beneficial ownership of all securities held by his spouse.